Mars will acquire US-based whole-fruit snacking brand Trü Frü to broaden its health and wellness portfolio.
Tru Fru will operate as an independent business and continue to be led by CEO, Brian Neville.
According to Neville, Mars shares a passion for healthier snacking and has the capabilities to take their company to the next level.
The transaction is subject to customary regulatory approvals and is expected to close in the first quarter of 2023.
Headquartered in West Valley City, Utah, with approximately 50 employees,
Trü Frü’s snacks are available in frozen and shelf-stable formats in US retailers.
Andrew Clarke noted that Trü Frü is a perfect complementary fit for their health and wellness portfolio, and their capabilities will help the brand strengthen its operations, broaden distribution and accelerate growth.
He added that Mars wants to be the preferred home for emerging and founder-led brands like Trü Frü.


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
TikTok Nears $400 Million Settlement With Trump Administration Over Child Privacy Lawsuit
Why financial hardship is more likely if you’re disabled or sick
Reliance Industries Reworks Jio IPO Into Fresh Share Sale Amid Valuation Talks
Novo Nordisk Shares Tumble After CagriSema Misses Key Trial Endpoint
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Britain has almost 1 million young people not in work or education – here’s what evidence shows can change that
Dell Stock Hits Record High After Trump Endorsement, AI Server Demand Fuels Rally
Debate over H-1B visas shines spotlight on US tech worker shortages
The Beauty Beneath the Expressway: A Journey from Self to Service
Asian Currencies Slide as Iran Tensions Boost Dollar and Oil Prices
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
AI-Driven Inflation Raises U.S. Consumer Prices, Goldman Sachs Says
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge
CSL Shares Crash as Profit Warning and $5 Billion Impairment Shake Investors
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 



